Vertex Pharmaceuticals (VRTX) Change in Cash (2009 - 2026)

Vertex Pharmaceuticals' Change in Cash history runs 18 years deep, the most recent figure standing at $417.1 million for Q1 2026.

• In Q1 2026, Change in Cash rose 268.46% year-over-year to $417.1 million; the TTM figure through Mar 2026 stood at $819.5 million (up 118.28% YoY), while the FY2025 annual figure was $515.6 million, up 108.89% from the prior year.
• Change in Cash was $417.1 million for Q1 2026 at Vertex Pharmaceuticals, up from $140.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.3 billion in Q4 2022 to a low of -$4.6 billion in Q2 2024.
• Historically, Change in Cash has averaged -$76.2 million across 5 years, with a median of $296.6 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Cash surged 554.96% in 2022, then sank 633.74% in 2024.
• A 5-year view of Change in Cash shows it stood at $1.3 billion in 2022, then slumped by 155.75% to -$744.3 million in 2023, then advanced by 9.19% to -$675.9 million in 2024, then surged by 120.71% to $140.0 million in 2025, then soared by 197.93% to $417.1 million in 2026.
• The last three Change in Cash figures came in at $417.1 million (Q1 2026), $140.0 million (Q4 2025), and -$34.2 million (Q3 2025), per Business Quant data.